Cite
MLA Citation
A.G. Duffy et al.. “Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750—an antisense oligonucleotide against eIF4E—in combination with irinotecan in solid tumors and irinotecan‐refractory colorectal cancer.” International journal of cancer, vol. 139, no. 7, n.d., pp. 1648–1657. http://access.bl.uk/ark:/81055/vdc_100034747801.0x000049